Patents by Inventor George L. Wilcox

George L. Wilcox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220002238
    Abstract: The invention provides a compound of formula I and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the formula I compounds, as well as methods of using such as therapeutic agents for the treatment of pain-related disorders and diseases and in combination with other therapeutic agents.
    Type: Application
    Filed: November 6, 2019
    Publication date: January 6, 2022
    Applicant: Regents of the University of Minnesota
    Inventors: Carolyn A. FAIRBANKS, Herbert T. NAGASAWA, George L. WILCOX, Cristina D. PETERSON, Kelley F. KITTO
  • Patent number: 6204271
    Abstract: A pharmaceutical analgesic composition comprise an opioid analgesic agent and moxonidine as a non-opioid agent with analgesic activity. Administration of an opioid analgesic agent and moxonidine as a non-opioid agent produces analgesia in the treatment of pain in mammals.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: March 20, 2001
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Carolyn A. Fairbanks, George L. Wilcox, Laura S. Stone, Kelley F. Kitto
  • Patent number: 6150419
    Abstract: A treatment and composition for neuropathic pain by administering an effective amount of agmatine.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: November 21, 2000
    Inventors: Carolyn A. Fairbanks, George L. Wilcox, Kristin Schreiber, Tinna Marie Laughlin
  • Patent number: 6117879
    Abstract: Moxonidine and its physiologically compatible acid-addition salts are used for the treatment and/or prophylaxis of nociceptive pain, and in particular nociceptive acute and chronic pain.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: September 12, 2000
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Carolyn A. Fairbanks, George L. Wilcox, Laura S. Stone, Kelley F. Kitto
  • Patent number: 6054461
    Abstract: A method of relieving neuropathic pain uses moxonidine and its physiologically compatible acid-addition salts for the treatment and/or prophylaxis of neuropathic pain. A composition comprising an effective amount of moxonidine, or a pharmaceutically acceptable salt thereof, in a pharmaceutically acceptable carrier, is administered to a subject in need of such treatment. The composition may be administered intrathecally.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: April 25, 2000
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Carolyn A. Fairbanks, George L. Wilcox, Tinna M. Laughin